PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
+26.39%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$78.2M
AUM Growth
+$78.2M
(-76%)
Cap. Flow
+$39.6M
Cap. Flow
% of AUM
50.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
UroGen Pharma
URGN
|
$26.2M |
| 2 |
Mersana Therapeutics
MRSN
|
$13.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 51.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UroGen Pharma
URGN
$900M
| $26.2M | 33.51% |
+1,451,329
| New | +$26.2M |
|
|
IMDZ
2
DELISTED
Immune Design Corp.
IMDZ
| $19.1M | 24.47% |
1,962,720
| – | – |
|
|
AGRX
3
DELISTED
Agile Therapeutics, Inc
AGRX
| $19M | 24.27% |
5,062,363
| – | – |
|
|
4
Mersana Therapeutics
MRSN
$36.5M
| $13.4M | 17.07% |
+955,709
| New | +$13.4M |
|
|
EGRX
5
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $535K | 0.68% |
3,652,284
| – | – |
|